A citation-based method for searching scientific literature

Scott A Waldman, Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, David S Weinberg. JAMA 2009
Times Cited: 83







List of co-cited articles
683 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
S L Carrithers, M T Barber, S Biswas, S J Parkinson, P K Park, S D Goldstein, S A Waldman. Proc Natl Acad Sci U S A 1996
178
43

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
97
34

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Ruth Birbe, Juan P Palazzo, Rhonda Walters, David Weinberg, Stephanie Schulz, Scott A Waldman. Hum Pathol 2005
91
33

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Stephanie Schulz, Terry Hyslop, Janis Haaf, Christine Bonaccorso, Karl Nielsen, Matthew E Witek, Ruth Birbe, Juan Palazzo, David Weinberg, Scott A Waldman. Clin Cancer Res 2006
64
42

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
101
30

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Glen S Frick, Giovanni M Pitari, David S Weinberg, Terry Hyslop, Stephanie Schulz, Scott A Waldman. Expert Rev Mol Diagn 2005
50
44

Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
K Shailubhai, H H Yu, K Karunanandaa, J Y Wang, S L Eber, Y Wang, N S Joo, H D Kim, B W Miedema, S Z Abbas,[...]. Cancer Res 2000
170
25

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.
Peng Li, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari. Am J Pathol 2007
86
25

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.
Daniel G Nicastri, John T Doucette, Tony E Godfrey, Steven J Hughes. J Mol Diagn 2007
86
25


Guanylyl cyclases and signaling by cyclic GMP.
K A Lucas, G M Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz, K P Chepenik, S A Waldman. Pharmacol Rev 2000
907
24

Expression of guanylin is downregulated in mouse and human intestinal adenomas.
K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
66
28

Escherichia coli heat-stable toxin receptors in human colonic tumors.
S L Carrithers, S J Parkinson, S Goldstein, P Park, D C Robertson, S A Waldman. Gastroenterology 1994
80
23

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
80
23

Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
S A Waldman, B Cagir, J Rakinic, R D Fry, S D Goldstein, G Isenberg, M Barber, S Biswas, C Minimo, J Palazzo,[...]. Dis Colon Rectum 1998
79
22

Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
Jean-François Haince, Michel Houde, Guillaume Beaudry, Sylvain L'espérance, Geneviève Garon, Marie Desaulniers, Laurie J Hafer, James I Heald, Stephen Lyle, Steven R Grossman,[...]. J Clin Pathol 2010
29
62

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
126
20

The staging of colorectal cancer: 2004 and beyond.
Carolyn C Compton, Frederick L Greene. CA Cancer J Clin 2004
298
20

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Richard Gray, Jennifer Barnwell, Christopher McConkey, Robert K Hills, Norman S Williams, David J Kerr. Lancet 2007
837
20

The paracrine hormone hypothesis of colorectal cancer.
G M Pitari, P Li, J E Lin, D Zuzga, A V Gibbons, A E Snook, S Schulz, S A Waldman. Clin Pharmacol Ther 2007
45
37

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
Adam E Snook, Benjamin J Stafford, Peng Li, Gene Tan, Lan Huang, Ruth Birbe, Stephanie Schulz, Matthias J Schnell, Mathew Thakur, Jay L Rothstein,[...]. J Natl Cancer Inst 2008
38
44

Micrometastases and survival in stage II colorectal cancer.
G J Liefers, A M Cleton-Jansen, C J van de Velde, J Hermans, J H van Krieken, C J Cornelisse, R A Tollenaar. N Engl J Med 1998
524
19

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
Christine M Ribic, Daniel J Sargent, Malcolm J Moore, Stephen N Thibodeau, Amy J French, Richard M Goldberg, Stanley R Hamilton, Pierre Laurent-Puig, Robert Gryfe, Lois E Shepherd,[...]. N Engl J Med 2003
18

Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer.
Terry Hyslop, David S Weinberg, Stephanie Schulz, Alan Barkun, Scott A Waldman. Clin Cancer Res 2011
20
75

Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.
Adam E Snook, Peng Li, Benjamin J Stafford, Elizabeth J Faul, Lan Huang, Ruth C Birbe, Alessandro Bombonati, Stephanie Schulz, Matthias J Schnell, Laurence C Eisenlohr,[...]. Cancer Res 2009
29
51

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Al B Benson, Deborah Schrag, Mark R Somerfield, Alfred M Cohen, Alvaro T Figueredo, Patrick J Flynn, Monika K Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem,[...]. J Clin Oncol 2004
964
16

Guanylyl cyclase is a heat-stable enterotoxin receptor.
S Schulz, C K Green, P S Yuen, D L Garbers. Cell 1990
527
15

Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Martin Beaulieu, Marie Desaulniers, Nicolas Bertrand, Réna G Deschesnes, Guillaume Beaudry, Geneviève Garon, Jean-François Haince, Michel Houde, Timothy J Holzer. Diagn Mol Pathol 2010
19
68

Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Daniel J Sargent, Murray B Resnick, Michael O Meyers, Atoussa Goldar-Najafi, Thomas Clancy, Sharlene Gill, Gary O Siemons, Qian Shi, Brian M Bot, Tsung-Teh Wu,[...]. Ann Surg Oncol 2011
23
56

Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Stephen L Carrithers, Cobern E Ott, Michael J Hill, Brett R Johnson, Weiyan Cai, Jason J Chang, Rajesh G Shah, Congmei Sun, Elizabeth A Mann, Manasses C Fonteles,[...]. Kidney Int 2004
71
16

Guanylin mRNA expression in human intestine and colorectal adenocarcinoma.
M B Cohen, J A Hawkins, D P Witte. Lab Invest 1998
73
16

Bacterial enterotoxins are associated with resistance to colon cancer.
G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic, S A Waldman. Proc Natl Acad Sci U S A 2003
116
14

The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
Matthew E Witek, Karl Nielsen, Rhonda Walters, Terry Hyslop, Juan Palazzo, Stephanie Schulz, Scott A Waldman. Clin Cancer Res 2005
70
17

Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation.
Kris A Steinbrecher, Steve A Wowk, Jeffrey A Rudolph, David P Witte, Mitchell B Cohen. Am J Pathol 2002
84
14

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004
14

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
14

Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Anton J Bilchik, Dave S B Hoon, Sukamal Saha, Roderick R Turner, David Wiese, Maggie DiNome, Kazuo Koyanagi, Martin McCarter, Perry Shen, Douglas Iddings,[...]. Ann Surg 2007
113
13

Systemic therapy for colorectal cancer.
Jeffrey A Meyerhardt, Robert J Mayer. N Engl J Med 2005
831
13

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
Thierry André, Corrado Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Andrea Bonetti, Philip Clingan, John Bridgewater, Fernando Rivera,[...]. J Clin Oncol 2009
13

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
Jessica B O'Connell, Melinda A Maggard, Clifford Y Ko. J Natl Cancer Inst 2004
12

Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
P Li, J E Lin, A E Snook, A V Gibbons, D S Zuzga, S Schulz, G M Pitari, S A Waldman. Clin Transl Sci 2008
17
58


Cancer statistics, 2007.
Ahmedin Jemal, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu, Michael J Thun. CA Cancer J Clin 2007
12

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
99
12

Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
A E Snook, L C Eisenlohr, J L Rothstein, S A Waldman. Clin Pharmacol Ther 2007
23
43

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
Yixin Wang, Tim Jatkoe, Yi Zhang, Matthew G Mutch, Dmitri Talantov, John Jiang, Howard L McLeod, David Atkins. J Clin Oncol 2004
343
10

Allelic loss of chromosome 18q and prognosis in colorectal cancer.
J Jen, H Kim, S Piantadosi, Z F Liu, R C Levitt, P Sistonen, K W Kinzler, B Vogelstein, S R Hamilton. N Engl J Med 1994
626
10

Binding of E. coli heat-stable enterotoxin to rat intestinal brush borders and to basolateral membranes.
A Guarino, M B Cohen, G Overmann, M R Thompson, R A Giannella. Dig Dis Sci 1987
62
14

Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins.
Giovanni M Pitari, Ronnie I Baksh, David M Harris, Peng Li, Shiva Kazerounian, Scott A Waldman. Cancer Res 2005
32
28

Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance.
C Ratto, L Sofo, M Ippoliti, M Merico, M Bossola, F M Vecchio, G B Doglietto, F Crucitti. Dis Colon Rectum 1999
144
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.